94. 原発性硬化性胆管炎 Primary sclerosing cholangitis Clinical trials / Disease details

臨床試験数 : 142 / 薬物数 : 113 - (DrugBank : 37) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 139

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00953615 (ClinicalTrials.gov)	April 2006	4/8/2009	Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)	Open Label, Phase II Investigation of Thalidomidefor the Treatment of Primary Sclerosing Cholangitis ...	Primary Sclerosing Cholangitis	Drug: Thalidomide	Mayo Clinic	Celgene Corporation	Terminated	18 Years	72 Years	All	1	Phase 2	United States